New product marketing blurs the line between nicotine replacement therapy and smokeless tobacco products

American Journal of Public Health

Volumn 106, Issue 7, 2016, Pages 1219-1222

  Kostygina, Ganna ^a   England, Lucinda ^b   Ling, Pamela ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE GUM;

ADVERTISING; ECONOMICS; HUMAN; LEGISLATION AND JURISPRUDENCE; MARKETING; ORGANIZATION AND MANAGEMENT; PROCEDURES; SMOKELESS TOBACCO; SMOKING CESSATION;

ADVERTISING AS TOPIC; HUMANS; MARKETING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO, SMOKELESS;

EID: 84974627437     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2016.303057     Document Type: Article

References (29)

1. Mejia AB, Ling PM. Tobacco industry consumer research on smokeless tobacco users and product development. Am J Public Health. 2010;100(1):78-87.
2. Craver R. Reynolds subsidiary selling smoking-cessation gum. Available at: http://www.journalnow.com/business/business-news/local/reynolds-subsidiaryselling-smoking-cessation-gum/article-c17a52e8-cca0-11e2-8683-0019bb30f31a.html. Accessed March 5, 2016.
3. Niconovum USA. Zonnic. Available at: https://www.zonnic.com/default. aspx#. Accessed March 5, 2016.
4. Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy for nicotine dependence. CA Cancer J Clin. 2005;55(5):281-299.
5. Russell M, Feyerabend C, Cole P. Plasma nicotine levels after cigarette smoking and chewing nicotine gum.BMJ. 1976;1(6017):1043-1046.
6. CSPnet. Reynolds readies nicotinereplacement therapy products, will launch Zonnic in Iowa in September; also testing e-cigs, pouches, pellets, extracts. Available at: http://www.cspnet. com/category-news/tobacco/articles/ reynolds-readies-nicotine-replacementtherapy-products. Accessed March 5, 2016.
7. Nicotine Assisted Reduction to Stop. London, England: Action on Smoking and Health; 2005.
8. Shahab L, Cummings KM, Hammond D, Borland R, West R, McNeill A. The impact of changing nicotine replacement therapy licensing laws in the United Kingdom: findings from the International Tobacco Control Four Country Survey. Addiction. 2009;104(8):1420-1427.
9. National Institute for Health and Care Excellence. Tobacco: harm-reduction approaches to smoking. Available at: http://www.ncsct.co.uk/usr/pub/NICE-Harm-reduction.pdf. Accessed March 5, 2016.
10. Food and Drug Administration. Nicotine replacement therapy labels may change. Available at: http://www.fda.gov/ForConsumers/ConsumerUpdates/ ucm345087.htm. Accessed March 5, 2016.
11. Niconovum USA. New FDA information and answers to other questions we hear a lot. Available at: https://www.zonnic.com/Frequently-Asked-Questions.aspx. Accessed March 5, 2016.
12. Niconovum USA. FDA consumer health information: nicotine replacement therapy labels may change. Available at: https://www.zonnic.com/pdf/NRT-Label-Change-0413.pdf. Accessed March 5, 2016.
13. Kozlowski LT, Giovino GA, Edwards B, et al. Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking. Addict Behav. 2007;32(10):2140-2150.
14. Pierce JP, Gilpin EA. Impact of overthe-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA. 2002;288(10):1260-1264.
15. Nicorette.Nicorette products.Available at: http://www.nicorette.com/nicorettemini-lozenge. Accessed March 5, 2016.
16. Reynolds American Inc. Niconovum Zonnic NRT Gum. Available at: http://vimeo.com/47451514. Accessed March 5, 2016.
17. Caria MP, Bellocco R, Zambon A, Horton NJ, Galanti MR. Overweight and perception of overweight as predictors of smokeless tobacco use and of cigarette smoking in a cohort of Swedish adolescents. Addiction. 2009;104(4): 661-668.
18. Craver R. Snus focus of yearlong study. Winston-Salem Journal. May 22, 2011. Available at: http://www.journalnow.com/business/article-19f644b0-4b16-5885-a34a-4ca8b63a4c0d.html. Accessed March 5, 2016.
19. Niconovum USA. Press images. Available at: http://www.niconovum.se/ PressImages.aspx. Accessed March 5, 2016.
20. Caldwell B, Burgess C, Crane J. Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers. Nicotine Tob Res. 2010; 12(2):179-183.
21. Altria Group. 2013 Investor Day. Available at: http://investor.altria.com/ phoenix.zhtml?c=80855&p=irol-EventDetails&EventId=5168875. Accessed March 5, 2016.
22. Craver R. Reynolds moves to be on top when smoke clears. Available at: http://www.journalnow.com/business/reynolds-moves-to-be-on-top-whensmoke-clears/article-aea2bfbb-c19b-502f-85f9-d068160b8009.html. Accessed March 5, 2016.
23. Food and Drug Administration. Modified risk tobacco products. Available at: http://www.fda.gov/ TobaccoProducts/Labeling/ TobaccoProductReviewEvaluation/ ucm304465.htm. Accessed March 5, 2016.
24. HIPAASpace. Nicotine Polarcrilex Gum. Available at: http://www.hipaaspace.com/Medical-Billing/Coding/National.Drug.Codes/11822-0854-1. Accessed March 5, 2016.
25. Peeters S, Gilmore AB. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials. PLoS Med. 2013;10(9): e1001506.
26. British American Tobacco. Other nicotine products. Available at: http://www.bat.com/nicotine. AccessedMarch 5, 2016.
27. Japan Tobacco. Pharmaceutical business. Available at: http://www.jt.com/about/division/pharma. Accessed March 5, 2016.
28. Delnevo CD, Wackowski OA, Giovenco DP, Manderski MT, Hrywna M, Ling PM. Examining market trends in the United States smokeless tobacco use: 2005-2011. Tob Control. 2014;23(2): 107-112.
29. TheHealthConsequences of Smoking- 50 Years of Progress: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services; 2014.